ATE427755T1 - Verwendung von lh fur die kontrollierte ovarielle hyperstimulation - Google Patents

Verwendung von lh fur die kontrollierte ovarielle hyperstimulation

Info

Publication number
ATE427755T1
ATE427755T1 AT02767637T AT02767637T ATE427755T1 AT E427755 T1 ATE427755 T1 AT E427755T1 AT 02767637 T AT02767637 T AT 02767637T AT 02767637 T AT02767637 T AT 02767637T AT E427755 T1 ATE427755 T1 AT E427755T1
Authority
AT
Austria
Prior art keywords
ovarian hyperstimulation
controlled ovarian
controlled
hyperstimulation
ovarian
Prior art date
Application number
AT02767637T
Other languages
English (en)
Inventor
Stephen Hillier
Colin Howles
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE427755(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of ATE427755T1 publication Critical patent/ATE427755T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT02767637T 2001-09-12 2002-09-12 Verwendung von lh fur die kontrollierte ovarielle hyperstimulation ATE427755T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01307755 2001-09-12

Publications (1)

Publication Number Publication Date
ATE427755T1 true ATE427755T1 (de) 2009-04-15

Family

ID=8182260

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02767637T ATE427755T1 (de) 2001-09-12 2002-09-12 Verwendung von lh fur die kontrollierte ovarielle hyperstimulation

Country Status (28)

Country Link
US (1) US7341989B2 (de)
EP (1) EP1434600B1 (de)
JP (1) JP2005504072A (de)
KR (1) KR20040032953A (de)
CN (1) CN1302806C (de)
AR (1) AR036591A1 (de)
AT (1) ATE427755T1 (de)
AU (1) AU2002331939B2 (de)
BR (1) BR0212502A (de)
CA (1) CA2457067A1 (de)
CY (1) CY1110487T1 (de)
DE (1) DE60231892D1 (de)
DK (1) DK1434600T3 (de)
EA (1) EA009210B1 (de)
ES (1) ES2322136T3 (de)
HK (1) HK1067866A1 (de)
HR (1) HRP20040070A2 (de)
IL (1) IL160781A0 (de)
ME (1) MEP38808A (de)
MX (1) MXPA04002125A (de)
NO (1) NO327154B1 (de)
PL (1) PL205472B1 (de)
PT (1) PT1434600E (de)
RS (1) RS51505B (de)
SI (1) SI1434600T1 (de)
UA (1) UA78970C2 (de)
WO (1) WO2003022301A2 (de)
ZA (1) ZA200401008B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0305033A (pt) * 2002-06-07 2004-11-09 Ares Trading Sa Uso de uma substância tendo atividade de hormÈnio luteinizante (substância lh), e, kit farmacêutico
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
CN102296047B (zh) * 2011-08-13 2013-03-13 新疆农垦科学院 利用羔羊超排卵母细胞生产体外胚胎的方法
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
RU2629871C1 (ru) * 2016-03-22 2017-09-04 Сергей Михайлович Юдин Препарат для стимуляции фолликулогенеза и способ его применения
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
ATE332705T1 (de) 1999-05-07 2006-08-15 Applied Research Systems Verwendung von in der mittlere oder späte follikuläre phase verabreichte lh zur behandlung von anovulatorischen frauen

Also Published As

Publication number Publication date
EA200400428A1 (ru) 2004-08-26
AR036591A1 (es) 2004-09-22
WO2003022301A3 (en) 2003-04-17
NO20040990L (no) 2004-03-08
US20050049199A1 (en) 2005-03-03
JP2005504072A (ja) 2005-02-10
HRP20040070A2 (en) 2004-10-31
DK1434600T3 (da) 2009-05-25
NO327154B1 (no) 2009-05-04
DE60231892D1 (de) 2009-05-20
CN1302806C (zh) 2007-03-07
RS51505B (sr) 2011-06-30
US7341989B2 (en) 2008-03-11
HK1067866A1 (en) 2005-04-22
EP1434600A2 (de) 2004-07-07
CA2457067A1 (en) 2003-03-20
BR0212502A (pt) 2004-08-24
CY1110487T1 (el) 2015-04-29
ES2322136T3 (es) 2009-06-17
PL205472B1 (pl) 2010-04-30
MXPA04002125A (es) 2004-07-08
YU21204A (sh) 2006-08-17
MEP38808A (en) 2011-02-10
EA009210B1 (ru) 2007-12-28
EP1434600B1 (de) 2009-04-08
KR20040032953A (ko) 2004-04-17
SI1434600T1 (sl) 2009-06-30
IL160781A0 (en) 2004-08-31
AU2002331939B2 (en) 2007-10-25
ZA200401008B (en) 2005-08-31
PT1434600E (pt) 2009-04-28
UA78970C2 (uk) 2007-05-10
WO2003022301A2 (en) 2003-03-20
PL367343A1 (en) 2005-02-21
CN1553809A (zh) 2004-12-08

Similar Documents

Publication Publication Date Title
DE60225081D1 (de) Herstellungsverfahren von Esterwachs
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
DE60221036D1 (de) Vorrichtung zum Erzeugen von Emulsionen
DE60329521D1 (de) Koordinierung von mehrschichtiger prozesssteuerung und optimierungsverfahren
DE50212455D1 (de) Verwendung von Dimerdiolen
ATE510556T1 (de) Verwendung von erythropoietin
DE02784674T1 (de) Quantifizierung von polypeptiden
DE60126838D1 (de) Amidoacetonitrile zur Bekämpfung von Endoparasiten
BR0205514B1 (pt) processos de tratamento de cabelo
NO20033679L (no) Nye pyrimidinforbindelser
FI20010979A (fi) Puhelunohjausmenetelmä
DE60221412D1 (de) Zonensteuerung
DE50204861D1 (de) Vorrichtung zum erzeugen von weisslicht
PT1401828E (pt) Compostos de n-formil-hidroxilamina como inibidores de pdf
ATE427755T1 (de) Verwendung von lh fur die kontrollierte ovarielle hyperstimulation
DE10295497D2 (de) Vernetzung von Photoinitiator-initialisierten Polyacrylaten
BR0307184B1 (pt) processo contÍnuo de hidrogenaÇço de compostos.
DE60130365D1 (de) Die Verwendung von Rosiglitazon zur Behandlung von psychiatrischen Erkrankungen.
BR0202786B1 (pt) processo de sìntese de uréia.
ATE344717T1 (de) Vorrichtung zum spanlosen trennen von kunstoffprofielen
DE50311406D1 (de) Verwendung von Formkörpern
DE60232935D1 (de) Herstellungsverfahren von Druckeinheiten
FI20010472A0 (fi) Menetelmä alfa-pineenin hydraamiseksi
DE60131682D1 (de) Biologische bekämpfung von pflanzenkrankheiten
ATE349556T1 (de) Verwendung von copolymerisaten als hilfsmittel für die lederherstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1434600

Country of ref document: EP

EEFA Change of the company name